US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Horizon Kinetics Blockchain Development ETF

32.42

+0.26630.83%

Volume:288

Turnover:9K

Market Cap:23.50M

PE:- -

High:32.42

Open:32.41

Low:32.41

Close:32.15

52wk High:36.27

52wk Low:29.01

Shares:725.00K

Float Shares:725.00K

Volume Ratio:0.15

T/O Rate:0.04%

Dividend:0.76

Dividend Rate:2.36%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Liberty Defense Sells Two Hexwave Screening Systems to Cleveland Hopkins Airport

Cycurion Regains NASDAQ $1 Minimum Bid-Price Compliance After Reverse Split

Subsea 7 Reports Share Dealings by Primary Insiders

Equinor Corrects Share Buyback Disclosure, Sets Total Transaction Value at NOK 1.14 Billion

Century Therapeutics Targets CNTY-813 IND Filing in Q4 2026, Sees Initial Trial Data in 2H 2027

Autonomix Medical Wins Canadian Patent for Catheter-Based Transvascular Nerve Therapy Platform

Integra LifeSciences Q3 Adjusted EPS Seen at $0.55-$0.59; Revenue Seen at $410-$412 Million

NN Inc Prices Unregistered PIPE at $3.30 Per Share for USD 50 Million Net Proceeds

Duke Robotics Names Avi Levin CFO, Replacing Shlomo Zakai

NetSol Technologies Names Michael Ramsey VP of Sales for Transcend Finance Americas

Constellation Software’s Volaris Acquires Brazil Corporate Foodservice Software Provider Teknisa

Surrozen Says FDA Clears IND for SZN-8141 Diabetic Macular Edema Trial

Thunder Bridge Capital Partners V Units Begin Separate Trading of Shares, Warrants Oct. 5

Taysha Gene Therapies Grants New Hires 384,000 RSUs, Options for 92,400 Shares Under Inducement Plan

Teva Says Phase 3 Ecopipam Trial Halves Tic Relapse Risk in Pediatric Tourette Syndrome Patients

Damora Therapeutics Grants Options for 144,400 Shares to New Hires at $21.28 Exercise Price

Cytokinetics to Present Four Aficamten Studies at HFSA Annual Scientific Meeting 2026

InflaRx to Present Late-Breaking Preclinical Izicopan Data at ASN Kidney Week 2026

Abeona Therapeutics Grants Inducement Awards for up to 7,200 Restricted Shares to New Hires

Kura Oncology Grants Inducement Stock Options for 128,250 Shares to Nine New Hires

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/BCDF/news?page=52"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BCDF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCDF\",,,,,undefined,":{"symbol":"BCDF","market":"US","secType":"STK","nameCN":"Horizon Kinetics Blockchain Development ETF","latestPrice":32.4203,"timestamp":1791576000000,"preClose":32.154,"halted":0,"volume":288,"delay":0,"changeRate":0.00828201778938838,"floatShares":725000,"shares":725000,"eps":0,"marketStatus":"Market Closed","change":0.2663,"latestTime":"10-09 16:00:00 EDT","open":32.405,"high":32.4203,"low":32.405,"amount":9329,"amplitude":0.000476,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":32.154,"sharesOutstanding":675000,"nav":32.09,"aum":23265250,"dividendRate":0.023565,"bidAskSpread":0,"volumeRatio":0.153158917022232},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCDF\",,,,,undefined,":{"symbol":"BCDF","floatShares":725000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.153158917022232,"shares":725000,"dividePrice":0.764,"high":32.4203,"amplitude":0.000476,"preClose":32.154,"low":32.405,"week52Low":29.01,"pbRate":"--","week52High":36.27,"institutionHeld":0,"latestPrice":32.4203,"eps":0,"divideRate":0.023565,"volume":288,"delay":0,"ttmEps":0,"open":32.405,"prevYearClose":30.2172,"prevWeekClose":31.9937,"prevMonthClose":32.0003,"prevQuarterClose":32.0003,"fiveDayClose":31.9937,"twentyDayClose":33.1605,"sixtyDayClose":31.6148},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BCDF\",params:#limit:5,,,undefined,":[{"date":"2024-12-24","symbol":"BCDF","amount":0.45302,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"Horizon Kinetics Blockchain Development ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"},{"date":"2023-12-27","symbol":"BCDF","amount":0.169967,"announcedDate":"2023-12-26","type":"dividend","market":"US","newRecordDate":"2023-12-28","defaultRemindTime":1703687400000,"name":"Horizon Kinetics Blockchain Development ETF","recordDate":"2023-12-29","payableDate":"2023-12-28","currency":"USD","dateTimestamp":1703653200000,"payDate":"2023-12-29"},{"market":"US","date":"2022-12-28","symbol":"BCDF","amount":0.05244,"defaultRemindTime":1672237800000,"name":"Horizon Kinetics Blockchain Development ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2022-09-28","symbol":"BCDF","amount":0.0219,"defaultRemindTime":1664371800000,"name":"Horizon Kinetics Blockchain Development ETF","recordDate":"2022-09-30","payableDate":"2022-09-29","currency":"USD","type":"dividend","dateTimestamp":1664337600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BCDF\",market:\"US\",,,undefined,":[{"executeDate":"2022-09-28","recordDate":"2022-09-29","paymentDate":"2022-09-30","value":0.0219,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.05244,"currency":"USD"},{"executeDate":"2023-12-27","recordDate":"2023-12-28","paymentDate":"2023-12-29","value":0.169967,"currency":"USD"},{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.45302,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BCDF\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BCDF\",pageSize:20,pageCount:52,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672680714","title":"Liberty Defense Sells Two Hexwave Screening Systems to Cleveland Hopkins Airport","url":"https://stock-news.laohu8.com/highlight/detail?id=2672680714","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672680714?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:30","pubTimestamp":1790944258,"startTime":"0","endTime":"0","summary":"Liberty Defense sells two HEXWAVE screening systems to Cleveland Hopkins airportLiberty Defense sold two HEXWAVE screening systems to Cleveland Hopkins International Airport for its aviation worker sc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL80QrSs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014005.SGD","BCDF","IE00BQXX3F31.USD","LU0314104364.USD","IE00BN0W2V16.EUR","BK4585","IE00BQXX3D17.EUR","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","LU2095319765.USD","IE00BN0W2W23.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","BK4588","IE00BQXX3C00.GBP","SG9999014039.USD","LU2210150020.SGD","LU2210149790.SGD","SG9999014021.USD","BK4112","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672971468","title":"Cycurion Regains NASDAQ $1 Minimum Bid-Price Compliance After Reverse Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2672971468","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672971468?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:30","pubTimestamp":1790944216,"startTime":"0","endTime":"0","summary":"Cycurion regains Nasdaq $1 minimum bid-price compliance after reverse splitWestern Acquisition Ventures Corp.-backed Cycurion regained compliance with Nasdaq’s $1.00 minimum bid price rule, removing a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL9TFQCv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","IE00BQXX3C00.GBP","BK4123","SG9999014013.SGD","IE00BQXX3D17.EUR","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","LU2095319765.USD","IE00BQXX3F31.USD","BK4585","IE00B64PRP62.GBP","SG9999014005.SGD","BCDF","LU2210149790.SGD","NDAQ","BK4112","LU0314104364.USD","IE00BKPKM429.USD","BK4588","IE00BGHQF748.EUR","SG9999014039.USD","IE00BN0W2V16.EUR","SG9999014021.USD","CYCU","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672711084","title":"Subsea 7 Reports Share Dealings by Primary Insiders","url":"https://stock-news.laohu8.com/highlight/detail?id=2672711084","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672711084?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:15","pubTimestamp":1790943353,"startTime":"0","endTime":"0","summary":"Subsea 7 reports share dealings by primary insidersSubsea 7 reported share transactions by primary insiders, disclosed under EU Market Abuse Regulation.Details of the dealing parties were not provided","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL5WFxXS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Subsea 7 Reports Share Dealings by Primary Insiders","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3C00.GBP","IE00B64PRP62.GBP","LU2210149790.SGD","LU0314104364.USD","NDAQ","SG9999014021.USD","BK4112","IE00BQXX3F31.USD","BK4585","BK4588","SG9999014039.USD","BCDF","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","LU2095319765.USD","SG9999014013.SGD","IE00BKPKM429.USD","LU2210150020.SGD","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","IE00BQXX3D17.EUR","IE00BGHQF748.EUR","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672741711","title":"Equinor Corrects Share Buyback Disclosure, Sets Total Transaction Value at NOK 1.14 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2672741711","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672741711?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:12","pubTimestamp":1790943171,"startTime":"0","endTime":"0","summary":"Equinor corrects share buyback disclosure, sets total transaction value at NOK 1.14 billionEquinor issued a correction to prior disclosures on its employee share buyback program, citing an incorrect s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL3lcj8m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","BK4585","SG9999014039.USD","IE00BQXX3D17.EUR","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","LU2095319765.USD","NDAQ","IE00BQXX3C00.GBP","BCDF","LU2210150020.SGD","BK4112","SG9999014013.SGD","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00B64PRP62.GBP","LU0314104364.USD","IE00BGHQF748.EUR","SG9999014021.USD","BK4588","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672371128","title":"Century Therapeutics Targets CNTY-813 IND Filing in Q4 2026, Sees Initial Trial Data in 2H 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2672371128","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672371128?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:05","pubTimestamp":1790942723,"startTime":"0","endTime":"0","summary":"Century Therapeutics targets CNTY-813 IND filing in Q4 2026, sees initial trial data in 2H 2027Century Therapeutics outlined new nonclinical results for CNTY-813, an iPSC-derived islet replacement the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL59y9r6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPSC","NDAQ","SG9999014013.SGD","SG9999014039.USD","IE00BQXX3D17.EUR","SG9999014021.USD","IE00BKPKM429.USD","BK4505","LU2095319765.USD","IE00BQXX3C00.GBP","IE00BGHQF748.EUR","BK4585","BK4139","LU2210150020.SGD","BK4112","BCDF","IE00B3QW5Z07.USD","IE00BQXX3F31.USD","BK4588","IE00B64PRP62.GBP","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","BK4539","IE00BN0W2V16.EUR","SG9999014005.SGD","LU0314104364.USD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672711404","title":"Autonomix Medical Wins Canadian Patent for Catheter-Based Transvascular Nerve Therapy Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2672711404","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672711404?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:05","pubTimestamp":1790942720,"startTime":"0","endTime":"0","summary":"Autonomix Medical wins Canadian patent for catheter-based transvascular nerve therapy platformAutonomix Medical received a Canadian patent covering catheter-based transvascular tools that access tissu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL2VQmvB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","IE00BGHQF748.EUR","BK4082","BK4112","LU2210149790.SGD","IE00BQXX3C00.GBP","BK4585","SG9999014013.SGD","IE00BKPKM429.USD","LU0314104364.USD","SG9999014021.USD","IE00B3QW5Z07.USD","BK4588","AMIX","BCDF","NDAQ","IE00BN0W2T93.GBP","SG9999014005.SGD","IE00BQXX3D17.EUR","SG9999014039.USD","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","LU2210150020.SGD","IE00BQXX3F31.USD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672711402","title":"Integra LifeSciences Q3 Adjusted EPS Seen at $0.55-$0.59; Revenue Seen at $410-$412 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2672711402","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672711402?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:05","pubTimestamp":1790942718,"startTime":"0","endTime":"0","summary":"Integra LifeSciences Q3 adjusted EPS seen at $0.55-$0.59; revenue seen at $410-$412 millionIntegra LifeSciences expects Q3 2026 revenue of about $410 million-$412 million; adjusted EPS seen at $0.55-$","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL4Cqnnc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","SG9999014005.SGD","IE00BQXX3D17.EUR","SG9999014021.USD","LU2095319765.USD","LU2210149790.SGD","SG9999014013.SGD","BK4585","BCDF","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","IE00B64PRP62.GBP","BK4082","IE00BQXX3C00.GBP","IE00BQXX3F31.USD","LU2210150020.SGD","IE00BN0W2T93.GBP","BK4112","LU0314104364.USD","IE00BGHQF748.EUR","BK4588","IART","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672711157","title":"NN Inc Prices Unregistered PIPE at $3.30 Per Share for USD 50 Million Net Proceeds","url":"https://stock-news.laohu8.com/highlight/detail?id=2672711157","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672711157?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:01","pubTimestamp":1790942517,"startTime":"0","endTime":"0","summary":"NN Inc prices unregistered PIPE at $3.30 per share for USD 50 million net proceedsNN Inc. priced a PIPE expected to deliver about USD 50 million in net proceeds, with closing targeted for Oct. 5, 2026","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL3JLgy2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","IE00BN0W2W23.USD","SG9999014013.SGD","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","BK4161","IE00BN0W2T93.GBP","NDAQ","NNBR","IE00BN0W2V16.EUR","IE00BKPKM429.USD","BCDF","IE00BQXX3C00.GBP","LU2210150020.SGD","BK4588","LU2210149790.SGD","LU0314104364.USD","BK4112","IE00B64PRP62.GBP","SG9999014039.USD","IE00BGHQF748.EUR","SG9999014021.USD","BK4585","SG9999014005.SGD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672871116","title":"Duke Robotics Names Avi Levin CFO, Replacing Shlomo Zakai","url":"https://stock-news.laohu8.com/highlight/detail?id=2672871116","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672871116?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:01","pubTimestamp":1790942498,"startTime":"0","endTime":"0","summary":"Duke Robotics names Avi Levin CFO, replacing Shlomo ZakaiDuke Robotics appointed Avi Levin as chief financial officer, effective Oct. 1, 2026.Levin succeeded Shlomo Zakai, who will continue providing ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL7zZw8k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","BCDF","NDAQ","IE00BGHQF748.EUR","DUKR","IE00BN0W2T93.GBP","IE00BKPKM429.USD","ABILF","BK4585","IE00BQXX3F31.USD","SG9999014021.USD","LU2095319765.USD","IE00BQXX3D17.EUR","SG9999014013.SGD","IE00BN0W2W23.USD","LU0314104364.USD","LU2210149790.SGD","BK4112","BK4588","IE00B3QW5Z07.USD","SG9999014005.SGD","SG9999014039.USD","BK4187","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672711167","title":"NetSol Technologies Names Michael Ramsey VP of Sales for Transcend Finance Americas","url":"https://stock-news.laohu8.com/highlight/detail?id=2672711167","media":"Reuters","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672711167?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:01","pubTimestamp":1790942474,"startTime":"0","endTime":"0","summary":"NetSol Technologies names Michael Ramsey VP of Sales for Transcend Finance AmericasNetSol Technologies appointed Michael Ramsey vice president of sales, Transcend Finance, Americas, based in Austin.Ra","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL6FKxWd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","BK4112","LU2210149790.SGD","SG9999014013.SGD","IE00BGHQF748.EUR","BK4588","NTWK","SG9999014005.SGD","IE00BQXX3D17.EUR","LU2095319765.USD","IE00B64PRP62.GBP","BK4585","IE00BN0W2V16.EUR","LU2210150020.SGD","NDAQ","IE00B3QW5Z07.USD","SG9999014039.USD","BCDF","LU0314104364.USD","IE00BQXX3C00.GBP","IE00BKPKM429.USD","BK4023","SG9999014021.USD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672111957","title":"Constellation Software’s Volaris Acquires Brazil Corporate Foodservice Software Provider Teknisa","url":"https://stock-news.laohu8.com/highlight/detail?id=2672111957","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672111957?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:01","pubTimestamp":1790942470,"startTime":"0","endTime":"0","summary":"Constellation Software’s Volaris acquires Brazil corporate foodservice software provider TeknisaVolaris Group, a Constellation Software unit, acquired Brazil-based Teknisa, a software provider for cor","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDLb0l6Pc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","IE00BN0W2V16.EUR","BCDF","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","SG9999014013.SGD","IE00B3QW5Z07.USD","IE00BQXX3D17.EUR","BK4585","IE00BGHQF748.EUR","IE00BN0W2W23.USD","BK4588","SG9999014039.USD","LU2210150020.SGD","NDAQ","BK4112","LU2095319765.USD","SG9999014005.SGD","IE00BKPKM429.USD","SG9999014021.USD","IE00BQXX3F31.USD","IE00BQXX3C00.GBP","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672991711","title":"Surrozen Says FDA Clears IND for SZN-8141 Diabetic Macular Edema Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2672991711","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672991711?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:00","pubTimestamp":1790942457,"startTime":"0","endTime":"0","summary":"Surrozen says FDA clears IND for SZN-8141 diabetic macular edema trialFDA cleared Surrozen’s IND for SZN-8141, an intravitreal DME candidate combining a Wnt agonist with a VEGF antagonist.First patien","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDLRKBdP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BGHQF748.EUR","SG9999014005.SGD","NDAQ","IE00BQXX3C00.GBP","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","BCDF","LU2210150020.SGD","BK4585","BK4112","IE00B3QW5Z07.USD","LU0314104364.USD","SRZN","SG9999014013.SGD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","SG9999014039.USD","BK4588","IE00BN0W2W23.USD","SG9999014021.USD","LU2210149790.SGD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672711945","title":"Thunder Bridge Capital Partners V Units Begin Separate Trading of Shares, Warrants Oct. 5","url":"https://stock-news.laohu8.com/highlight/detail?id=2672711945","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672711945?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:00","pubTimestamp":1790942455,"startTime":"0","endTime":"0","summary":"Thunder Bridge Capital Partners V units begin separate trading of shares, warrants Oct. 5Thunder Bridge Capital Partners V will allow holders of 30,015,000 IPO units to split shares from warrants star","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDLbKXNqX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3F31.USD","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","IE00BQXX3D17.EUR","SG9999014021.USD","LU2095319765.USD","BK4588","IE00BQXX3C00.GBP","LU2210150020.SGD","LU0314104364.USD","BCDF","IE00BN0W2T93.GBP","SG9999014005.SGD","BK4585","BK4112","IE00B64PRP62.GBP","IE00BN0W2W23.USD","IE00BKPKM429.USD","SG9999014039.USD","SG9999014013.SGD","TBCVU","IE00BGHQF748.EUR","NDAQ","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672119437","title":"Taysha Gene Therapies Grants New Hires 384,000 RSUs, Options for 92,400 Shares Under Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2672119437","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672119437?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:00","pubTimestamp":1790942450,"startTime":"0","endTime":"0","summary":"Taysha Gene Therapies grants new hires 384,000 RSUs, options for 92,400 shares under inducement planTaysha Gene Therapies granted four new employees 384,000 restricted stock units under its 2023 Induc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL5N4d6y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BGHQF748.EUR","SG9999014005.SGD","NDAQ","IE00BQXX3C00.GBP","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","BCDF","LU2210150020.SGD","BK4585","BK4112","IE00B3QW5Z07.USD","LU0314104364.USD","SG9999014013.SGD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","SG9999014039.USD","BK4588","IE00BN0W2W23.USD","SG9999014021.USD","LU2210149790.SGD","LU2095319765.USD","TSHA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672711918","title":"Teva Says Phase 3 Ecopipam Trial Halves Tic Relapse Risk in Pediatric Tourette Syndrome Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2672711918","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672711918?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:00","pubTimestamp":1790942449,"startTime":"0","endTime":"0","summary":"Teva says Phase 3 ecopipam trial halves tic relapse risk in pediatric Tourette syndrome patientsTeva highlighted aJournal of Child Neurologyreview of clinical-trial evidence for investigational Touret","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL1MrfwT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","BK4112","LU2210149790.SGD","IE00BKPKM429.USD","IE00BQXX3D17.EUR","NDAQ","IE00BGHQF748.EUR","LU0314104364.USD","BK4585","LU2210150020.SGD","SG9999014021.USD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","LU2095319765.USD","SG9999014013.SGD","SG9999014005.SGD","IE00B64PRP62.GBP","IE00BQXX3C00.GBP","BK4588","SG9999014039.USD","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","BCDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672711617","title":"Damora Therapeutics Grants Options for 144,400 Shares to New Hires at $21.28 Exercise Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2672711617","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672711617?lang=en_us&edition=fundamental","pubTime":"2026-10-02 19:59","pubTimestamp":1790942351,"startTime":"0","endTime":"0","summary":"Damora Therapeutics grants options for 144,400 shares to new hires at $21.28 exercise priceDamora Therapeutics granted inducement stock options covering 144,400 ordinary shares to five newly hired non","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDLBMWn5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","NDAQ","IE00BQXX3C00.GBP","LU2210150020.SGD","IE00B64PRP62.GBP","IE00BQXX3F31.USD","LU2210149790.SGD","IE00BGHQF748.EUR","SG9999014013.SGD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","BK4588","SG9999014005.SGD","IE00BN0W2W23.USD","IE00BQXX3D17.EUR","DMRA","BCDF","SG9999014021.USD","BK4585","LU2095319765.USD","SG9999014039.USD","BK4139","IE00B3QW5Z07.USD","LU0314104364.USD","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672719786","title":"Cytokinetics to Present Four Aficamten Studies at HFSA Annual Scientific Meeting 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672719786","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672719786?lang=en_us&edition=fundamental","pubTime":"2026-10-02 19:30","pubTimestamp":1790940656,"startTime":"0","endTime":"0","summary":"Cytokinetics to present four aficamten studies at HFSA Annual Scientific Meeting 2026Cytokinetics will present new aficamten data at the HFSA Annual Scientific Meeting in Phoenix, Oct. 9-12, 2026.Late","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL73qHP6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014005.SGD","BCDF","IE00BN0W2W23.USD","IE00BQXX3F31.USD","BK4588","BK4112","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","LU0314104364.USD","BK4505","IE00B64PRP62.GBP","LU2210149790.SGD","SG9999014021.USD","SG9999014039.USD","BK4585","LU2095319765.USD","CYTK","IE00BQXX3D17.EUR","SG9999014013.SGD","IE00BQXX3C00.GBP","BK4139","IE00BKPKM429.USD","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672197897","title":"InflaRx to Present Late-Breaking Preclinical Izicopan Data at ASN Kidney Week 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672197897","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672197897?lang=en_us&edition=fundamental","pubTime":"2026-10-02 19:30","pubTimestamp":1790940645,"startTime":"0","endTime":"0","summary":"InflaRx to present late-breaking preclinical izicopan data at ASN Kidney Week 2026InflaRx announced it will present late-breaking preclinical data on oral C5aR1 antagonist izicopan at Kidney Week 2026","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL788LN6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00B64PRP62.GBP","LU2095319765.USD","IE00BQXX3C00.GBP","IE00BKPKM429.USD","IE00BN0W2V16.EUR","BK4585","IE00BQXX3D17.EUR","BCDF","SG9999014039.USD","BK4588","SG9999014005.SGD","IFRX","BK4112","BK4139","NDAQ","SG9999014013.SGD","LU0314104364.USD","IE00BN0W2W23.USD","SG9999014021.USD","LU2210149790.SGD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672209719","title":"Abeona Therapeutics Grants Inducement Awards for up to 7,200 Restricted Shares to New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2672209719","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672209719?lang=en_us&edition=fundamental","pubTime":"2026-10-02 19:30","pubTimestamp":1790940617,"startTime":"0","endTime":"0","summary":"Abeona Therapeutics grants inducement awards for up to 7,200 restricted shares to new hiresGranted inducement restricted stock awards covering up to 7,200 shares to two newly hired non-executive emplo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL6d7tcx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","LU0314104364.USD","BK4585","LU2095319765.USD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","IE00BKPKM429.USD","IE00BQXX3D17.EUR","SG9999014021.USD","IE00B64PRP62.GBP","IE00BQXX3C00.GBP","SG9999014039.USD","ABEO","SG9999014005.SGD","BK4112","BK4588","IE00BN0W2W23.USD","LU2210149790.SGD","LU2210150020.SGD","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","BCDF","SG9999014013.SGD","IE00BGHQF748.EUR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672192077","title":"Kura Oncology Grants Inducement Stock Options for 128,250 Shares to Nine New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2672192077","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672192077?lang=en_us&edition=fundamental","pubTime":"2026-10-02 19:30","pubTimestamp":1790940614,"startTime":"0","endTime":"0","summary":"Kura Oncology grants inducement stock options for 128,250 shares to nine new hiresKura Oncology granted nonstatutory stock options covering 128,250 shares to nine new employees on Oct. 1, 2026.Options","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL59ylpK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","KURA","IE00BN0W2T93.GBP","IE00BQXX3D17.EUR","IE00B64PRP62.GBP","SG9999014039.USD","LU2210150020.SGD","SG9999014021.USD","IE00BN0W2V16.EUR","BK4139","BK4505","IE00BKPKM429.USD","SG9999014005.SGD","IE00BQXX3C00.GBP","LU0314104364.USD","SG9999014013.SGD","IE00BQXX3F31.USD","IE00B3QW5Z07.USD","LU2210149790.SGD","BK4112","IE00BGHQF748.EUR","LU2095319765.USD","BK4588","IE00BN0W2W23.USD","BK4585","BCDF"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":93,"pageCount":52,"totalSize":1857,"code":"91000000","status":"200"}]}}